title: Helicobacter pylori eradication: do we have another ace up our sleeve?
authors.forename: A
authors.initials: A
authors.lastname: Zullo
authors.forename: C
authors.initials: C
authors.lastname: Hassan
authors.forename: R
authors.initials: R
authors.lastname: Lorenzetti
authors.forename: S
authors.initials: S
authors.lastname: Morini
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D005756:Gastritis / Q000382:microbiology; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D015242:Ofloxacin / Q000627:therapeutic use*; D009853:Omeprazole / Q000031:analogs & derivatives; D064750:Rabeprazole
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000890:Anti-Infective Agents; D001562:Benzimidazoles; D064750:Rabeprazole; D015242:Ofloxacin; D000251:Adenosine Triphosphatases; D009853:Omeprazole